ID IRF2_MOUSE Reviewed; 349 AA. AC P23906; DT 01-NOV-1991, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1991, sequence version 1. DT 24-JAN-2024, entry version 185. DE RecName: Full=Interferon regulatory factor 2; DE Short=IRF-2; GN Name=Irf2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=2475256; DOI=10.1016/0092-8674(89)90107-4; RA Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., RA Miyata T., Taniguchi T.; RT "Structurally similar but functionally distinct factors, IRF-1 and IRF-2, RT bind to the same regulatory elements of IFN and IFN-inducible genes."; RL Cell 58:729-739(1989). RN [2] RP PROTEIN SEQUENCE OF 108-120, AND IDENTIFICATION BY MASS SPECTROMETRY. RC STRAIN=OF1; TISSUE=Hippocampus; RA Lubec G., Sunyer B., Chen W.-Q.; RL Submitted (JAN-2009) to UniProtKB. RN [3] RP STRUCTURE BY NMR OF 2-113. RX PubMed=9562558; DOI=10.1016/s0969-2126(98)00050-1; RA Furui J., Uegaki K., Yamazaki T., Shirakawa M., Swindells M.B., Harada H., RA Taniguchi T., Kyogoku Y.; RT "Solution structure of the IRF-2 DNA-binding domain: a novel subgroup of RT the winged helix-turn-helix family."; RL Structure 6:491-500(1998). RN [4] RP X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-113. RX PubMed=10487755; DOI=10.1093/emboj/18.18.5028; RA Fujii Y., Shimizu T., Kusumoto M., Kyogoku Y., Taniguchi T., Hakoshima T.; RT "Crystal structure of an IRF-DNA complex reveals novel DNA recognition and RT cooperative binding to a tandem repeat of core sequences."; RL EMBO J. 18:5028-5041(1999). CC -!- FUNCTION: Specifically binds to the upstream regulatory region of type CC I IFN and IFN-inducible MHC class I genes (the interferon consensus CC sequence (ICS)) and represses those genes. Also acts as an activator CC for several genes including H4 and IL7. Constitutively binds to the CC ISRE promoter to activate IL7. Involved in cell cycle regulation CC through binding the site II (HiNF-M) promoter region of H4 and CC activating transcription during cell growth. Antagonizes IRF1 CC transcriptional activation. CC -!- SUBUNIT: Interacts with BRD7, IRF2BP1 and IRF2BP2. Interacts with CC CREBBP in growing cells; the interaction acetylates IRF2 and regulates CC IRF2-dependent H4 promoter activity (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Nucleus. CC -!- INDUCTION: By viruses and IFN. CC -!- PTM: Acetylated by CBP/ p300 during cell-growth. Acetylation on Lys-75 CC is required for stimulation of H4 promoter activity (By similarity). CC {ECO:0000250}. CC -!- PTM: The major sites of sumoylation are Lys-137 and Lys-293. CC Sumoylation with SUMO1 increases its transcriptional repressor activity CC on IRF1 and diminishes its ability to activate ISRE and H4 promoter (By CC similarity). {ECO:0000250}. CC -!- SIMILARITY: Belongs to the IRF family. {ECO:0000255|PROSITE- CC ProRule:PRU00840}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J03168; AAA39333.1; -; mRNA. DR CCDS; CCDS22295.1; -. DR RefSeq; NP_032417.3; NM_008391.4. DR RefSeq; XP_006509351.1; XM_006509288.3. DR RefSeq; XP_006509352.1; XM_006509289.3. DR PDB; 1IRF; NMR; -; A=2-113. DR PDB; 1IRG; NMR; -; A=2-113. DR PDB; 2IRF; X-ray; 2.20 A; G/H/I/J/K/L=1-113. DR PDBsum; 1IRF; -. DR PDBsum; 1IRG; -. DR PDBsum; 2IRF; -. DR AlphaFoldDB; P23906; -. DR BMRB; P23906; -. DR SMR; P23906; -. DR BioGRID; 200785; 4. DR STRING; 10090.ENSMUSP00000034041; -. DR iPTMnet; P23906; -. DR PhosphoSitePlus; P23906; -. DR jPOST; P23906; -. DR PaxDb; 10090-ENSMUSP00000034041; -. DR PeptideAtlas; P23906; -. DR ProteomicsDB; 267006; -. DR Pumba; P23906; -. DR Antibodypedia; 17374; 614 antibodies from 45 providers. DR DNASU; 16363; -. DR Ensembl; ENSMUST00000034041.9; ENSMUSP00000034041.8; ENSMUSG00000031627.10. DR GeneID; 16363; -. DR KEGG; mmu:16363; -. DR UCSC; uc009lqo.2; mouse. DR AGR; MGI:96591; -. DR CTD; 3660; -. DR MGI; MGI:96591; Irf2. DR VEuPathDB; HostDB:ENSMUSG00000031627; -. DR eggNOG; ENOG502QW7C; Eukaryota. DR GeneTree; ENSGT00940000159063; -. DR HOGENOM; CLU_056386_0_0_1; -. DR InParanoid; P23906; -. DR OMA; SSWPPFA; -. DR OrthoDB; 3740806at2759; -. DR PhylomeDB; P23906; -. DR TreeFam; TF328512; -. DR BioGRID-ORCS; 16363; 12 hits in 81 CRISPR screens. DR ChiTaRS; Irf2; mouse. DR EvolutionaryTrace; P23906; -. DR PRO; PR:P23906; -. DR Proteomes; UP000000589; Chromosome 8. DR RNAct; P23906; Protein. DR Bgee; ENSMUSG00000031627; Expressed in granulocyte and 207 other cell types or tissues. DR ExpressionAtlas; P23906; baseline and differential. DR GO; GO:0005829; C:cytosol; ISO:MGI. DR GO; GO:0005925; C:focal adhesion; ISO:MGI. DR GO; GO:0005654; C:nucleoplasm; ISO:MGI. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0003677; F:DNA binding; ISO:MGI. DR GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:MGI. DR GO; GO:0003700; F:DNA-binding transcription factor activity; IMP:MGI. DR GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central. DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central. DR GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:MGI. DR GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:MGI. DR GO; GO:0051607; P:defense response to virus; ISO:MGI. DR GO; GO:0002376; P:immune system process; IBA:GO_Central. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI. DR GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:MGI. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IMP:MGI. DR GO; GO:0034138; P:toll-like receptor 3 signaling pathway; ISO:MGI. DR CDD; cd00103; IRF; 1. DR Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1. DR InterPro; IPR019817; Interferon_reg_fac_CS. DR InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom. DR InterPro; IPR017431; IRF1/IRF2. DR InterPro; IPR036388; WH-like_DNA-bd_sf. DR InterPro; IPR036390; WH_DNA-bd_sf. DR PANTHER; PTHR11949; INTERFERON REGULATORY FACTOR; 1. DR PANTHER; PTHR11949:SF22; INTERFERON REGULATORY FACTOR 2; 1. DR Pfam; PF00605; IRF; 1. DR PIRSF; PIRSF038196; IFN_RF1/2; 1. DR PRINTS; PR00267; INTFRNREGFCT. DR SMART; SM00348; IRF; 1. DR SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1. DR PROSITE; PS00601; IRF_1; 1. DR PROSITE; PS51507; IRF_2; 1. DR Genevisible; P23906; MM. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Activator; Direct protein sequencing; KW DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome; KW Repressor; Transcription; Transcription regulation; Ubl conjugation. FT CHAIN 1..349 FT /note="Interferon regulatory factor 2" FT /id="PRO_0000154550" FT DNA_BIND 5..113 FT /note="IRF tryptophan pentad repeat" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00840" FT REGION 230..253 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 303..349 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 305..321 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 75 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P14316" FT MOD_RES 78 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P14316" FT MOD_RES 225 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P14316" FT CROSSLNK 137 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO); alternate" FT /evidence="ECO:0000250" FT CROSSLNK 137 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2); alternate" FT /evidence="ECO:0000250|UniProtKB:P14316" FT CROSSLNK 166 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO)" FT /evidence="ECO:0000250" FT CROSSLNK 260 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:P14316" FT CROSSLNK 293 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO)" FT /evidence="ECO:0000250" FT HELIX 8..17 FT /evidence="ECO:0007829|PDB:2IRF" FT STRAND 25..28 FT /evidence="ECO:0007829|PDB:2IRF" FT TURN 29..32 FT /evidence="ECO:0007829|PDB:2IRF" FT STRAND 33..37 FT /evidence="ECO:0007829|PDB:2IRF" FT STRAND 43..47 FT /evidence="ECO:0007829|PDB:1IRF" FT HELIX 48..51 FT /evidence="ECO:0007829|PDB:2IRF" FT HELIX 53..61 FT /evidence="ECO:0007829|PDB:2IRF" FT TURN 67..69 FT /evidence="ECO:0007829|PDB:2IRF" FT HELIX 74..87 FT /evidence="ECO:0007829|PDB:2IRF" FT STRAND 91..93 FT /evidence="ECO:0007829|PDB:2IRF" FT TURN 95..97 FT /evidence="ECO:0007829|PDB:2IRF" FT STRAND 98..100 FT /evidence="ECO:0007829|PDB:1IRG" FT STRAND 106..111 FT /evidence="ECO:0007829|PDB:2IRF" SQ SEQUENCE 349 AA; 39453 MW; 8738B082FB40FB11 CRC64; MPVERMRMRP WLEEQINSNT IPGLKWLNKE KKIFQIPWMH AARHGWDVEK DAPLFRNWAI HTGKHQPGID KPDPKTWKAN FRCAMNSLPD IEEVKDRSIK KGNNAFRVYR MLPLSERPSK KGKKPKTEKE ERVKHIKQEP VESSLGLSNG VSGFSPEYAV LTSAIKNEVD STVNIIVVGQ SHLDSNIEDQ EIVTNPPDIC QVVEVTTESD DQPVSMSELY PLQISPVSSY AESETTDSVA SDEENAEGRP HWRKRSIEGK QYLSNMGTRN TYLLPSMATF VTSNKPDLQV TIKEDSCPMP YNSSWPPFTD LPLPAPVTPT PSSSRPDRET RASVIKKTSD ITQARVKSC //